Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PMCID: PMC4180391
Studies show that 25-40% of weight lost on these drugs is lean body massthe metabolically active tissue that actually matters for long-term health
In the STEP and SURMOUNT trial programs, participants treated with semaglutide and tirzepatide respectively achieved average weight reductions of 15 to 22% of total body weight, losses that had previously been achievable only through bariatric surgery [8,9]
Yes, when given by trained doctors using quality ingredients, it is very safe
In a study of adipose mass, growth therapy treatment for 26 weeks resulted in: Subcutaneous fat mass decreased by 13% Intra-abdominal fat mass reduced by 30% Lean body mass increased by 3-11% Aerobic function improved by 11-19% Muscle strength increased by 7-19% These changes continued during one year of treatment resulting in a 22% reduction in overall fat mass and a 61% reduction in belly fat
US$ 27.78
US$ 24.24
US$ 26.98
US$ 24.64
US$ 24.30
US$ 27.02
US$ 20.80
US$ 25.71
US$ 28.91
US$ 26.03
